Track every registration update on the InsiderAlpha IPO tracker.
Updated Jul 16, 2026 · Last SEC filing 2026-06-17
Eloxx Pharmaceuticals, Inc. (ELOX) has filed 11 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-17. 2 Form 8-K material event filings were reported by ELOX in the last 90 days. InsiderAlpha tracks every ELOX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001035354 |
|---|
| Form 4 filings (90d) | 11 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Latest Form 4 filing | 2026-06-17 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Domicilium Real Estate Fund III LP | 10% Owner | J — Other acquisition / disposition | 238.4K | — | — | SEC | |
| Domicilium Real Estate Fund III LP | 10% Owner | J — Other acquisition / disposition | 361.6K | — | — | SEC | |
| Coastlands Capital LP | 10% Owner | J — Other acquisition / disposition | 1.25M | $0.00 | — | SEC | |
| Domicilium Real Estate Fund III LP | 10% Owner | J — Other acquisition / disposition | 113.6K | $0.00 | — | SEC | |
| Aggarwal Sumit | President and CEO | M — Option exercise | 260.9K | $0.15 | $39K | SEC | |
| Walts Alan Edmund | Insider | M — Option exercise | 1.9K | — | — | SEC | |
| Aggarwal Sumit | President and CEO | M — Option exercise | 15.0K | — | — | SEC | |
| Rubin Steven D | Insider | M — Option exercise | 1.9K | — | — | SEC | |
| Aggarwal Sumit | President and CEO | A — Grant or award | 1.00M | $0.00 | — | SEC | |
| Aggarwal Sumit | President and CEO | M — Option exercise | 196.9K | $0.00 | $20 | SEC | |
| Aggarwal Sumit | PRESIDENT AND CEO | A — Grant or award | 165.0K | $0.00 | — | SEC | |
| Rubin Steven D | Director | A — Grant or award | 12.0K | $0.00 | — | SEC | |
| Walts Alan Edmund | Director | A — Grant or award | 12.0K | $0.00 | — | SEC | |
| Androski Lindsay | Director | A — Grant or award | 12.0K | $0.00 | — | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Eloxx Pharmaceuticals, Inc. (ELOX). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Aggarwal Sumit | 21 | $39K |
| Domicilium Real Estate Fund III LP | 6 | — |
| Rubin Steven D | 4 | — |
| Walts Alan Edmund | 4 | — |
| Coastlands Capital LP | 2 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ELOX insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live ELOX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.